-

Cadence Expands Pfizer’s License to Molecular Design Software

Includes access to computational software designed to help advance innovation in traditional and AI-based drug discovery

SAN JOSE, Calif.--(BUSINESS WIRE)--Cadence Molecular Sciences (OpenEye)—a business unit of Cadence Design Systems (Nasdaq: CDNS)—announced today that Pfizer Inc. has signed an agreement to extend and expand access to Cadence® products and programming toolkits for advanced molecular design.

“We’re excited to continue to support Pfizer as they innovate across their therapeutic portfolio, utilizing this unique set of research tools to aid in their early-stage drug discovery process,” said Anthony Nicholls, PhD, corporate vice president, Cadence Molecular Sciences. “As we expand this agreement with Pfizer, we hope to continue to enable high-quality science at the frontier of medicine.”

Cadence Molecular Sciences’ physics-and AI-based modeling and cheminformatics computational software is an enabler of early-stage drug discovery innovation. The software is used by major pharmaceutical and biotech companies worldwide to help accelerate and advance therapeutic research.

“Cadence’s molecular design technology continues to be an important resource to help us progress our early scientific discovery efforts across our therapeutic portfolio,” said Sergio Rotstein, vice president, Digital R&D Solutions, Pfizer.

To learn more about Cadence Molecular Sciences (OpenEye) and its technologies, please visit https://www.cadence.com/openeye.

About Cadence

Cadence is a pivotal leader in electronic design, building upon more than 30 years of computational software expertise. The company applies its underlying Intelligent System Design strategy to deliver software, hardware and IP that turn design concepts into reality. Cadence customers are the world’s most innovative companies, delivering extraordinary electronic products from chips to boards to complete systems for the most dynamic market applications, including hyperscale computing, 5G communications, automotive, mobile, aerospace, consumer, industrial and healthcare. For nine years in a row, Fortune magazine named Cadence one of the 100 Best Companies to Work For. Learn more at www.cadence.com.

© 2023 Cadence Design Systems, Inc. All rights reserved worldwide. Cadence, the Cadence logo and the other Cadence marks found at www.cadence.com/go/trademarks are trademarks or registered trademarks of Cadence Design Systems, Inc. All other trademarks are the property of their respective owners.

Category: Featured

Contacts

For more information, please contact:
Cadence Newsroom
408-944-7039
newsroom@cadence.com

Cadence Design Systems, Inc.

NASDAQ:CDNS
Details
Headquarters: San Jose, California
CEO: Anirudh Devgan
Employees: 12700
Organization: PUB
Revenues: 4.641 Billion (2024)
Net Income: 1.055 Billion (2024)

Release Summary
Cadence Molecular Sciences (OpenEye) announced today that Pfizer Inc. has signed an agreement to extend and expand access to Cadence products.
Release Versions

Contacts

For more information, please contact:
Cadence Newsroom
408-944-7039
newsroom@cadence.com

More News From Cadence Design Systems, Inc.

Cadence Announces Fourth Quarter and Fiscal Year 2025 Financial Results Webcast

SAN JOSE, Calif.--(BUSINESS WIRE)--Cadence (Nasdaq: CDNS) will hold its fourth quarter and fiscal year 2025 financial results webcast on Tuesday, February 17, 2026. Participating in the webcast will be Dr. Anirudh Devgan, president and chief executive officer, and John Wall, senior vice president and chief financial officer. The webcast will begin Tuesday, February 17, 2026, at 2:00 p.m. Pacific Time. An archive of the webcast will be available online from 5:00 p.m. Pacific Time on February 17,...

Cadence Launches Partner Ecosystem to Accelerate Chiplet Time to Market

SAN JOSE, Calif.--(BUSINESS WIRE)--Cadence's new Chiplet Spec-to-Packaged Parts partner ecosystem reduces engineering complexity and accelerates time to market for chiplet development....

Cadence’s Anirudh Devgan to Present at Nasdaq Investor Conference

SAN JOSE, Calif.--(BUSINESS WIRE)--Cadence’s Anirudh Devgan to Present at Nasdaq Investor Conference...
Back to Newsroom